Search the Newsreel

How Expanded Coverage for Guardant’s Shield Test Will Impact UnitedHealth Group (UNH) Investors

UnitedHealth Group's decision to cover Guardant Health's Shield blood test for colorectal cancer screening for roughly 40 million members over 45 aligns with its focus on preventive care. While this move supports UnitedHealth's long-term investment narrative through innovation and efficiency, it's overshadowed by ongoing …

AMBP: Fair Value View Balances Raised Expectations With Persistent Demand Concerns

Analysts have increased their price target for Ardagh Metal Packaging (AMBP) to $4.74, up from $4.50, due to updated fair value, discount rate, growth, profitability, and future P/E assumptions, despite ongoing mixed demand commentary in the packaging sector. While some bullish analysts see upside …

Guardant Health Inc (GH) four-week climb reaches 33.7%

The healthcare diagnostics name remains in an active weekly trend, with participation above its recent average and momentum still firm.

Guardant Health Inc (GH) reaches 113.7% 12-week gain with active trend

The precision-oncology diagnostics stock enters July with strong multiweek gains, though participation readings are not fully aligned.

Price to book forward of Sharda Motor Industries Ltd. – NSE:SHARDAMOTR

Guardant Health Inc (GH) volume spike sharpens weekly momentum setup

A 13.2% latest-week gain put the precision-oncology diagnostics name back on active-mover screens.

Guardant Health Inc (GH) climbs 13.2% as turnover expands

The precision-oncology diagnostics stock extended a strong 12-week run, with heavy weekly activity supporting the move.

SHARDACROP Forecast — Price Target — Prediction for 2027

Guardant Health Inc (GH) carries a 38.7% four-week climb into weekly view

The precision-oncology testing stock remains in an active weekly trend, but volume and relative-strength readings keep the confirmation from looking one-sided.

Guardant Health’s Trend Signal turns back on at 97% of its yearly range, despite 0.9x volume

The precision-oncology diagnostics stock added 4.8% in the latest week and is now 2.0% below its 52-week high, but participation has not yet matched the strength of the price move.

Guardant Health Inc (GH) lifts four-week run to 38.7%

The precision-oncology diagnostics stock remains in constructive weekly context, though confirmation is not uniform.

Guardant Health Inc (GH) posts another weekly gain within 54.5% 12-week run

The precision-oncology testing stock remains in an active weekly trend, though participation is not fully matching the price move.

We Think That There Are Some Issues For Sharda Motor Industries (NSE:SHARDAMOTR) Beyond Its Promising Earnings

SARDAEN: Strong profit growth and major capacity expansion approved amid robust power segment performance

SARDAEN: FY26 saw record revenue, PAT, and energy-led growth, with robust expansion and strong cash flows

Sharda Motor Industries Q4 PAT rises 7% YoY to Rs 89 crore

Sharda Cropchem's (NSE:SHARDACROP) Earnings Are Weaker Than They Seem

Guardant Health stock gains on early FDA approval for G360 test

Sharda Cropchem FY26 Net Profit Jumps 124% to ₹681 Cr

Sharda Cropchem falls 12% despite Q4 PAT rises 57%; ₹9 dividend declared

Does Sarda Energy & Minerals (NSE:SARDAEN) Deserve A Spot On Your Watchlist?

Sharda Crop Standalone March 2026 Net Sales at Rs 1,870.77 crore, up 15.88% Y-o-Y

SHARDACROP: Record FY26 profit and margin gains on 22% revenue growth, led by agrochemical segment

Guardant Health (NASDAQ:GH) Delivers Impressive Q1 CY2026, Stock Soars

Guardant Health (GH) Reports Q1 Loss, Beats Revenue Estimates

Guardant Health Earnings: What To Look For From GH

Sarda Energy gains 5% after HDFC Sec initiates coverage with 'buy' rating

Guardant Health Stock Rises on Japan Regulatory News for Daiichi Sankyo Drug - News and Statistics

Sarda Energy & Minerals: Co. Merging Kalyani Coal Mining Into Sarda Energy Ltd.

Sarda Energy Clarifies Volume Movement Following Supreme Court SKS Power Order

Sharda Motor Industries Gets Major Tax Relief; Tax Demand Likely to Drop

Sharda Cropchem Limited Receives Credit Rating Reaffirmation from Crisil for Rs. 456 Crore Bank Facilities

Sharda Motor Industries Reports 27.8% Revenue Growth in Q3FY26, Makes Conference Call Recording Available

Sharda Cropchem Shares Q3FY26 Earnings Call Insights with Strong Growth Outlook

Sharda Cropchem (NSE:SHARDACROP) Has Announced A Dividend Of ₹6.00

Sharda Motor Industries Announces Senior Management Restructuring Under Regulation 30